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Latent TGF-β binding protein 2 
and 4 have essential overlapping 
functions in microfibril 
development
Yusuke Fujikawa1,2, Hideyuki Yoshida1,3, Tadashi Inoue1,4, Tetsuya Ohbayashi5, 
Kazuo Noda6, Harald von Melchner7, Toshiji Iwasaka2, Ichiro Shiojima2, Tomoya O. Akama1 & 
Tomoyuki Nakamura1
Microfibrils are exracellular matrix components necessary for elastic fiber assembly and for suspending 
lenses. We previously reported that latent TGF-β binding protein 2 (LTBP-2), a microfibril-associated 
protein, is required for forming stable microfibril bundles in ciliary zonules. However, it was not 
understood why Ltbp2 null mice only showed an eye-specific phenotype, whereas LTBP-2 is abundantly 
expressed in other tissues containing microfibrils in wild type mice. Here, we show that LTBP-4, 
another microfibril-associated protein, compensates for the loss of LTBP-2 in microfibril formation. 
Ltbp2/4S double knockout (DKO) mice showed increased lethality due to emphysema, which was 
much more severe than that found in Ltbp4S null mice. Elastic fibers in the lungs of Ltbp2/4S DKO 
mice were severely disorganized and fragmented. Cultured mouse embryonic fibroblasts (MEFs) from 
Ltbp2/4S DKO embryos developed reduced microfibril meshwork in serum-free conditions, whereas the 
microfibril formation was restored by the addition of either recombinant LTBP-2 or -4. Finally, ectopic 
expression of LTBP-4 in the whole body restored ciliary zonule microfibril bundles in the eyes of Ltbp2 
null mice. These data suggest that LTBP-2 and -4 have critical overlapping functions in forming the 
robust structure of microfibrils in vitro and in vivo.
Microfibrils are abundantly distributed extracellular matrix (ECM) components. Some of these serve as a scaffold 
for tropoelastin deposition to form elastic fibers, whereas others constitute a structural unit without elastin, as 
in ciliary zonules1,2. Microfibrils are composed of homopolymers of fibrillin-1 and -2 together with associat-
ing proteins such as latent TGF-β binding proteins (LTBPs) and microfibril-associated glycoproteins (MAGPs). 
Fibrillin-1 and -2 are the defective gene products in Marfan syndrome and congenital contractural arachnodac-
tily, respectively. Microfibrils are organized into various architectures to accommodate the mechanical require-
ments of different tissues. For example, ciliary zonules in the eye are composed of a thick bundle of microfibrils 
that conduct tension between the lens and ciliary bodies, whereas in the skin, loosely assembled microfibrils 
extend from the epidermal basement membrane to the reticular dermis to connect with dermal elastic fibers3. In 
arteries, elastic fibers form a lamellar structure to constitute elastic lamellae. Therefore, microfibrils that provide 
scaffolds for elastin deposition should also be configured as a lamellar meshwork. The factors that determine the 
architectures of microfibrils between different tissues remain poorly understood, although microfibril-associating 
molecules likely play an important role.
LTBPs are multi-domain ECM proteins with molecular masses of 150–220 kDa which share structural homol-
ogy with fibrillins4–6. Among the four LTBPs, LTBP-1 and -3 play major roles in regulating TGF-β bioavailability 
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by tethering TGF-β propeptide (latency-associated peptide or LAP) that binds to mature TGF-β , thus facili-
tating the secretion, storage in the ECM, and activation of TGF-β . These LTBPs associate with the LAPs of all 
three TGF-β isoforms; however, LTBP-4 only interacts with TGF-β 1-LAP and does so very inefficiently, whereas 
LTBP-2 does not interact with any TGF-β -LAP complexes4–6. Therefore, the primary roles of LTBP-2 and -4 are 
considered TGF-β -independent.
There have been several reports of human patients with homozygous LTBP2 null mutations, who suffer from 
glaucoma with high intraocular pressure (IOP), ectopia lentis, megalocornea and microspherophakia7–12. We 
previously showed that Ltbp2 null mice exhibit fragmented ciliary zonules leading to lens dislocation13. Using cell 
culture and organ explant culture, we demonstrated that LTBP-2 is required for the formation of stable microfibril 
bundles in ciliary zonules. However, it is not understood why patients with LTBP2 mutations or Ltbp2 null mice 
only show eye-related phenotypes, whereas LTBP-2 is abundantly expressed in other tissues such as lungs and 
arteries that are rich in elastic fibers in wild type mice14–16.
LTBP-4 plays a major role in elastic fiber development. Homozygous LTBP4 mutations in humans were 
reported to cause cutis laxa type 2, a condition characterized by loose skin and emphysema17. Mice lacking 
LTBP-4S, which is the major splicing form expressed in the lungs and intestine, exhibit severely fragmented 
elastic fibers resulting in emphysematous lungs and stiff arteries18. We previously demonstrated that LTBP-4 
promotes elastin deposition onto microfibrils through interaction of LTBP-4 with fibulin-5 and fibulin-5 with 
elastin19. However, any role of LTBP-4 in microfibril development is not known.
Here, we show overlapping functions of LTBP-2 and -4 in microfibril development. While Ltbp4S null mice 
show emphysematous lungs and Ltbp2 null mice have no phenotype in organs other than the eyes, Ltbp2/4S 
DKO mice exhibit a much more severe form of emphysema than that found in Ltbp4S null mice, which was 
associated with increased mortality. The abrogated microfibril formation observed in Ltbp2/4S DKO MEFs cul-
tured in serum-free conditions was rescued by the addition of either recombinant LTBP-2 or -4. In addition, 
ectopic expression of LTBP-4 in Ltbp2 null mouse eyes restored stable ciliary zonules. This novel function of 
LTBP-4 in the development of microfibrils, at least in part, explains the absence of an extra-ocular phenotype in 
LTBP2-deficient patients.
Results
Ltbp1 and 3, but not 4, mRNA was abundantly expressed in the ciliary bodies of wild type and 
Ltbp2 null mice. Assuming that other LTBPs may compensate for the loss of LTBP-2 in stable microfibril 
formation in tissues other than the eyes in Ltbp2 null mice, we analyzed the expression of Ltbp1, 2, 3, and 4 mRNA 
in the lungs, aortae, and ciliary bodies of wild type and Ltbp2 null mice using RT-PCR (Fig. 1). Ltbp1 and 3 were 
expressed in ciliary bodies and in other tissues in both wild type and Ltbp2 null mice, indicating that LTBP-1 
and -3 were not able to compensate for the loss of LTBP-2. On the other hand, only a trace amount of Ltbp4 was 
expressed in ciliary bodies, while it was abundantly expressed in the lungs and aortae, suggesting that LTBP-4 is 
a candidate molecule that could substitute for LTBP-2 to enable stable microfibril formation in tissues other than 
the eyes.
Figure 1. Expression of genes of the LTBP family in mouse tissues. Gene expression of Ltbp1, 2, 3 and 4 and 
Gapdh in ciliary bodies, aorta and lung tissues from wild type (+ /+ ) and Ltbp2−/− (− /− ) mice was analyzed 
using RT-PCR. Expression of Ltbp4 was hardly detected in ciliary body tissues from either wild type or Ltbp2−/− 
mice.
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Ltbp2/4S DKO mice had a higher mortality rate than that of Ltbp2 or 4S single KO mice. To 
assess whether LTBP-4 compensated for the loss of LTBP-2 in Ltbp2 null mice, we generated Ltbp2/4S DKO 
mice. Since Ltbp2 null mice do not have any embryonic and reproductive abnormalities, we set up an Ltbp2−/−; 
Ltbp4S+/− intercross to produce Ltbp2−/−; Ltbp4S−/− (Ltbp2/4S DKO) mice. Approximately 50% of Ltbp2/4S DKO 
mice did not survive until the weaning period (4 weeks after birth). We evaluated the survival rate of Ltbp2/4S 
DKO mice along with that of other genotypes in every week after birth (Supplementary Fig. S1a). Mice having a 
genotype of either Ltbp2−/−; Ltbp4S+/+ or Ltbp2−/−; Ltbp4S+/− did not show a major decrease in survival rate at 4 
weeks after birth, and most of the Ltbp2/4S DKO mice survived by 3 weeks after birth. However, the survival rate 
of DKO mice suddenly decreased by 50% at 4 weeks after birth (Fig. 2). Dabovic et al., reported that Ltbp4S null 
mice show moderate lethality by 4 weeks after birth20. However, we analyzed the survival rate of Ltbp4S null mice 
at 4 weeks after birth and did not observe lethality (Fig. 2 and Supplementary Fig. S1b), indicating that juvenile 
lethality we found in our mutant mice was caused by the cooperative effect of LTBP-2 and LTBP-4 deficiencies. 
Interestingly, 70% of the Ltbp2/4S DKO mice that survived for 4 weeks after birth remained alive for 2 months or 
more after birth, suggesting a major critical period for survival of Ltbp2/4S DKO mice was between 3 weeks and 
4 weeks after birth.
Vascular impairment in Ltbp2/4S DKO mice was similar to that found in Ltbp4S null mice. To 
understand the cause of increased lethality in Ltbp2/4S DKO mice, we analyzed the physical characteristics and 
tissue abnormalities in 8-week-old mice of all genotypes, including Ltbp2/4S DKO mice. Systolic, diastolic, and 
mean blood pressure were not different between the genotypes. However, the body weight of Ltbp2/4S DKO mice 
was significantly decreased compared with that of mice of other genotypes (Supplementary Fig. S2).
We reported that Ltbp4S null mice show aortic tortuosity at day 5 after birth19. We confirmed that neonatal 
mice of both Ltbp4S null and Ltbp2/4S DKO genotypes showed tortuous aorta (Supplementary Fig. S3a), although 
aortic tortuosity became less obvious in adult animals (8-week-old, Supplementary Fig. S3b). Mice with both wild 
type and Ltbp2 null genotypes showed no evident aortic abnormalities at the neonatal stage or the adult stage. 
Although microfibril defects in arteries were expected to result in ascending aortic aneurysm as occurs in Marfan 
syndrome caused by fibrillin-1 mutations, Ltbp2/4S DKO mice did not show apparent aneurysms.
Ltbp2/4S DKO mice show more severe emphysema than that found in Ltbp4S null mice. Ltbp4S 
null mice were reported to develop pulmonary emphysema18,21. Macroscopic examination confirmed obvious 
emphysema in Ltbp4S mice, and notably, Ltbp2/4S DKO mice showed a more severe form of emphysema than 
that found in Ltbp4S null mice (Fig. 3). Remarkably large terminal air sacs, indicative of disruption of alveolar 
walls, were observed in the lungs of Ltbp2/4S DKO mice (Fig. 3). We then conducted histological analysis of 
the lungs of wild type and mutant mice at different developmental stages. Lung development in mice proceeds 
after birth with terminal air sac septation and alveolarization occurring between P0.5 and P2120. Before birth, 
lung morphology was indistinguishable among wild type, Ltbp2 null, and Ltbp4S null mice, whereas the lungs of 
Ltbp2/4S DKO mouse had larger terminal air sacs, indicating a septation defect (Fig. 4a). At 8 weeks after birth, 
the lungs of wild type and Ltbp2 null mice showed normal development. However, airspace enlargement was 
observed in the lungs of adult Ltbp4S null mice, and these defects were even more evident in the lung of Ltbp2/4S 
DKO mice (Fig. 4b).
Degradation or impairment of elastic fibers is a major cause of emphysema22. Thus, we next analyzed elastic 
fibers in lung ECM, using electron microscopy. Elastic fibers were visualized by tannic acid staining. Continuous 
thick elastic fibers were observed along the alveolar walls in wild type and Ltbp2 null mice (Fig. 4c). These tannic 
acid-positive elastic fibers were fragmented as dot-like deposits in the lungs of Ltbp4S null mice (Fig. 4c). We also 
observed microfibril bundles devoid of elastin deposition in Ltbp4S null tissues, as previously reported21, indi-
cating an essential function of LTBP-4 in mediating the proper assembly of elastin on microfibrils19. In Ltbp2/4S 
Figure 2. Survival rate of Ltbp2/4S mutant mice after birth. Starting from postnatal day 7 (P7), pups of wild 
type, Ltbp4S−/− mice (produced by intercross of Ltbp4S+/− mice), Ltbp2−/− mice, and Ltbp2−/−; Ltbp4S−/− mice 
(produced by intercross of Ltbp2−/− and Ltbp4S+/− mice) were evaluated for survival every week. *P < 0.05, 
determined by log-rank test.
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DKO lungs, we only observed smaller pieces of fragmented elastic fibers than in Ltbp4S null lung (Fig. 4c). Unlike 
Ltbp4S null tissue, we did not observe microfibril bundles without elastin deposition in Ltbp2/4S DKO tissue. 
Immunofluorescent staining of adult lungs using an anti-fibrillin-1 antibody revealed microfibrils in the wall of 
alveoli and blood vessels (Fig. 4d). Fibrillin microfibrils in the lungs of Ltbp2/4S DKO mice appeared discontinu-
ous compared with those in lung tissues of the other genotypes. These results suggest that the severe emphysema-
tous phenotype observed in Ltbp2/4S DKO mice could be attributable to degenerated elastic fibers with inefficient 
formation of bundled microfibrils, in addition to the terminal air sac septation defect.
Expression of elastogenic genes was enhanced at 3 weeks after birth but largely reduced at 8 
weeks after birth in Ltbp2/4S DKO mouse lung tissue. Severe disruption of elastic fibers and alve-
olar walls in Ltbp2/4S DKO mouse lungs suggested impaired elastogenesis and/or an increase in elastolysis in 
these tissues. Therefore, we analyzed the mRNA expression level of the genes involved in elastic fiber forma-
tion and degradation in the lungs at different developmental stages. In neonatal lungs, the expression levels of 
ECM-related genes were not drastically changed, and the differences from wild type mice were less than 2-fold 
(Supplementary Fig. S4a). However, at 3 weeks after birth, when Ltbp2/4S DKO mice showed partial lethality 
(Fig. 2), the expression levels of Eln and Fbn2 were increased about 10-fold and 3-fold, respectively, in Ltbp2/4S 
DKO mouse lungs, compared with that of wild type lungs (Supplementary Fig. S4b). The increase in Fbn1 and Lox 
expression in Ltbp2/4S DKO tissues was not statistically significant, but these data indicate compensatory expres-
sion of Eln but no notable increase in elastolytic metalloproteases. These findings suggested that disruption of 
elastic fibers was primarily caused by defects in elastic fiber formation in Ltbp2/4S DKO lung tissues at this stage, 
rather than by degradation of elastic fibers. At 8 weeks after birth, which is the period when surviving Ltbp2/S 
DKO mice develop advanced-stage emphysema, Eln expression approached the normal level, and expression of 
other elastogenic genes, including Fn1, Fbn1, Fbn2, Fbln4, Fbln5, and Lox was dramatically decreased, whereas 
the expression level of Mmp12 (macrophage elastase) was increased nearly 3-fold (Supplementary Fig. S4c). These 
data suggest that elastic fiber-producing mesenchymal cells were impaired and that the MMP-12 produced by 
macrophages further degraded elastic fibers in Ltbp2/4S DKO mouse lung tissues at this stage.
Either LTBP-2 or -4 is necessary for microfibril formation in serum-free culture of mouse embry-
onic fibroblasts. To test the hypothesis that LTBP-4 compensates for the loss of LTBP-2 in microfibril for-
mation, we analyzed microfibril formation in vitro using cultured mouse embryonic fibroblasts (MEFs) obtained 
from mutant mouse embryos. MEFs were cultured in serum-free media for 4 days and immunostained with 
anti-fibrillin-1 (for microfibril formation) as well as anti-LTBP-2 and -4 antibodies. Wild type MEFs produced 
a fibrillin-1–positive microfibril meshwork on the cells, and Ltbp2 null MEFs and Ltbp4S null MEFs showed 
slightly reduced signals by anti-fibrillin-1 antibody staining (Fig. 5a–c). Notably, microfibril meshwork forma-
tion was significantly abrogated in Ltbp2/4S DKO MEFs (Fig. 5d, and Supplementary Fig. S5a), but was rescued 
by the addition of either 5 nM of recombinant LTBP-2 or -4S (Fig. 5E,F, and Supplementary Fig. S5a). mRNA 
expression of Fbn1 and Fbn2 was even increased in Ltbp2/4S DKO MEFs by 2-fold compared to WT MEFs 
Figure 3. Gross morphology of Ltbp2/4S mutant lung in 8-week-old mice. Mild and severe emphysematous 
phenotypes were observed in Ltbp4S−/− and Ltbp2/4S DKO mice, respectively.
www.nature.com/scientificreports/
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(Supplementary Fig. S5b). These data indicate that either LTBP-2 or LTBP-4S is required for fibrillin-positive 
microfibril meshwork formation under serum-free conditions. However, microfibril meshwork formation 
was indistinguishable between the genotypes when cells were cultured in 3% serum-containing medium 
(Supplementary Fig. S6), suggesting that an unknown element(s) contained in fetal bovine serum promoted 
microfibril formation without a requirement for endogenous LTBPs. In contrast, elastin deposition onto microfi-
brils, which was visualized by immunostaining with anti-elastin and anti-fibulin-5 antibodies after cells were 
cultured in 10% serum-containing media for 14 days, strictly depended on the presence of LTBP-4S protein, with 
or without LTBP-2 (Supplementary Figs S7 and S8).
Figure 4. Histological analysis of Ltbp2/4S mutant mouse lungs. (a) Lung sections of mice at embryonic day 
18.5 (E18.5) were stained with hematoxylin and eosin. Bars: 400 μ m. (b) Lung sections of 8-week-old mice were 
stained with hematoxylin and eosin. Bars: 100 μ m. The terminal air sac enlargement in the lungs of Ltbp2/4S 
DKO mice was more severe than that observed in the lungs of Ltbp4S−/− mice. (c) Electron micrographs of 
elastic fibers stained black by tannic acid in the lungs of 8-week-old mice. The elastic fibers of Ltbp4S−/− and 
Ltbp2/4S DKO lungs were disorganized. Note bare microfibril bundles (open arrow) and elastin deposits outside 
microfibrils (closed arrow) in Ltbp4S−/− lung tissues. In Ltbp2/4S DKO lung tissues, bare microfibril bundles 
were not observed, and elastic fibers were more severely fragmented. Bars: 1 μ m. (d) Distribution of microfibrils 
in the lungs of 8-week-old mice. Cryosections of mouse lungs were stained with a rabbit anti-fibrillin-1 
antibody and visualized using an Alexa-488-labeled anti-rabbit IgG antibody. Nuclei were stained with Hoechst 
33258. Bars: 50 μ m.
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Disruption of ciliary zonules in Ltbp2 null mice was compensated by ectopic LTBP-4 overexpres-
sion. Next, we overexpressed LTBP-4 in the eyes of mice with an Ltbp2 null background, to assess whether 
LTBP-4 could compensate for the loss of LTBP-2 in vivo. Knock-in mice that had a CAG-promoter-driven Ltbp4S 
cDNA at the Rosa26 locus displayed enhanced expression of Ltbp4S in the whole body, and survived to adulthood 
without any gross malformation (Supplementary Fig. S9). These mice were crossed with Ltbp2 null mice to obtain 
Ltbp2 null; Ltbp4S KI mice. Without the Ltbp4S knock-in allele, eyes from 4-week-old Ltbp2 null mice exhibited 
fragmented ciliary zonules (Fig. 6a,b). However, the zonules were partially restored by the presence of ectopically 
expressed LTBP-4S in the eyes of Ltbp2 null; Ltbp4S KI mice (Fig. 6c), while LTBP-4S protein co-localized with 
the fibrillin-1 present in ciliary zonule microfibrils. These data indicated that LTBP-2 and -4 have an overlapping 
functions in forming the robust architecture of ciliary zonules in vivo.
Discussion
The storage of TGF-β in a latent form in the extracellular space is one of the major functions of LTBPs. However, 
LTBP-2 and -4 also have TGF-β -independent roles, as LTBP-2 does not bind TGF-β , and only small proportion of 
LTBP-4 binds TGF-β 4,5,23. We and others have reported such TGF-β -independent functions of LTBPs, especially 
in the development of microfibrils and elastic fibers. LTBP-2 deficiency causes lens luxation due to ciliary zonule 
fragmentation in humans and mice, suggesting that the function of LTBP-2 is associated with the formation 
of the robust structure of ciliary zonules consisting of fibrillin-microfibrils13. Although LTBP-2 is expressed in 
tissues other than the eyes that are abundant in microfibrils and elastic fibers, such as the lungs and arteries15,16, 
the function of LTBP-2 in these tissues has not been defined, as LTBP-2 deficiency only affected the eyes. On the 
other hand, we reported that LTBP-4 promotes deposition of elastin onto microfibrils in a TGF-β -independent 
manner, which is a critical step in elastic fiber assembly, whereas no role of LTBP-4 in microfibril formation has 
been deteremined19. In the current study, we determined that LTBP-2 and LTBP-4 have overlapping functions 
that enable the production of stable microfibril structures in vitro and in vivo.
Ltbp4S null mice develop pulmonary emphysema and cardiomyopathy18. The life span of Ltbp4S null mice is 
variable. Sterner-Kock et al. reported that the homozygous mutant mice survived until 6 months of age18, whereas 
Dabovic et al. reported a lethality rate of about 30% in homozygous mice by 21 days after birth20. In our study, 
Figure 5. Microfibril formation on cultured MEFs from mutant mice. MEFs of all genotypes were cultured 
in serum-free media for four days, and the ECM was stained with anti-fibrillin-1, anti-LTBP-2, and anti-LTBP-4 
antibodies, followed by fluorophore-labeled secondary antibodies corresponding to each first antibody (green 
for fibrillin-1, white for LTBP-2, and red for LTBP-4). Nuclei were stained with Hoechst 33258. MEFs lacking 
either LTBP-2 (b) or LTBP-4S (c) produced a weak but clear fibrillin-1 meshwork as observed in wild type MEFs 
(a), whereas MEFs lacking both LTBP-2 and LTBP-4S only produced aggregated deposition but no fibrous 
fibrillin-1–positive meshwork (d). Supplementation of recombinant protein of LTBP-2 (e) or LTBP-4S (f) at a 
concentration of 5 nM into the cultured medium restored microfibril meshwork formation on Ltbp2/4S DKO 
MEFs. Bars: 150 μ m.
www.nature.com/scientificreports/
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Ltbp4S null homozygous mice did not show lethality by at least 4 weeks after birth, consistent with the previous 
report from 200218. This variation in the survival rate may be due to the different genetic background of the 
mutant mice.
Whereas Ltbp2 null mice and Ltbp4S null mice did not exhibit increased lethality by 4 weeks after birth, 
approximately half of the Ltbp2/4S DKO mice died at this time point. A more severe form of emphysema than that 
in Ltbp4S null mice was the only critical phenotype we observed that could affect the life span of Ltbp2/4S DKO 
mice. Elastic fibers in the lungs of Ltbp2/4S DKO mice were markedly fragmented, which could account for the 
severe emphysema observed. Because elastic fibers are composed of microfibrils and elastin, and expression of the 
Eln gene was upregulated in the lungs of 3-week-old Ltbp2/4S DKO mice, defects in elastic fibers in these tissues 
were attributed to defects in microfibrils and/or elastin assembly onto microfibrils. Microfibril bundles without 
elastin deposition were observed in Ltbp4S null mice, as previously reported21, which is indicative of defective 
elastin deposition onto microfibrils. The absence of such bare microfibril bundles in Ltbp2/4S DKO lungs sug-
gests that the microfibril structure itself was affected in these tissues (Fig. 4c). The fragmented fibrillin-1 staining 
pattern observed in the lungs of Ltbp2/4S DKO mice supports this notion (Fig. 4d). We observed elevated Mmp12 
gene expression in the lungs of surviving 8-week-old Ltbp2/4S DKO mice, which could have been caused by 
chemotactic function of fragmented elastic fibers. At this advanced stage, degradation of elastic fibers by MMP-12 
was considered to additively contribute to further impairment in elastic fibers in these tissues.
Another possible explanation is that LTBP-2 and -4 may be protecting microfibrils from enzymatic degrada-
tion, rather than forming microfibrils. Further examinations such as time-course of fibrillin-1 immunostaining 
of lungs and protease resistance assay of microfibrils would elucidate the molecular function of LTBP-2 and -4.
Mutations in the FBN1 gene cause Marfan syndrome, one of the major symptoms of which is aortic aneu-
rysm24. Because fibrillin-1 is the main component of microfibrils, we reasoned that microfibril defects in Ltbp2/4S 
Figure 6. Restoration of ciliary zonule formation in Ltbp2−/−; Ltbp4S KI mice. Ltbp4S KI mice ubiquitously 
expressed LTBP-4S in the whole body, including ciliary bodies, whereas LTBP-4 was not expressed in ciliary 
bodies of wild type mice. By crossing these mice with Ltbp2−/− mice, Ltbp2−/−; Ltbp4S KI mice were produced, 
and ciliary zonule formation of the mouse eyes was visualized using immunofluorescent analysis, as in Fig. 5. 
LTBP-2 and fibrillin-1 co-localized on ciliary zonules of wild type mouse eyes, but fibrous fibrillin-1 staining 
was largely absent in the Ltbp2−/− eye. Ectopic expression of LTBP-4 in ciliary bodies restored ciliary zonule 
formation in Ltbp2−/−; Ltbp4S KI mouse eyes. Bars: 100 μ m.
www.nature.com/scientificreports/
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DKO mice could cause aneurysms, which turned out not to be the case. One possibility is that the architecture of 
microfibrils differs between tissues, and the microfibril architecture in arteries does not require LTBP-2 and -4. 
Elastic fibers in arteries form a unique structure called elastic lamellae. Therefore, microfibrils that provide scaf-
folds for elastin deposition could also form a lamellar meshwork that is different from microfibril structures 
found in the eyes and lungs. Another possible explanation is that aneurysms in Marfan syndrome are caused by 
a disturbance of signaling maintained by fibrillin-1, and not by defects in microfibril structure per se. It has been 
reported that antagonizing TGF-β signaling or angiotensin II signaling suppresses the development of aneurysms 
in Fbn1 mutant mice or Marfan syndrome patients, even though these drugs does not correct the structural prob-
lems in microfibrils caused by mutant fibrillin-125.
Culturing of MEFs required LTBP-2 or -4 for the development of a microfibril meshwork in the absence of 
fetal bovine serum, although neither of these was necessary for microfibril formation in the presence of serum. 
These data suggest that circulating LTBP-2, -4, or unknown factors in the serum promoted microfibril formation 
in the absence of endogenous LTBP-2 and -4. Further study is necessary to identify such circulating factors that 
facilitate microfibril development.
Ectopically overexpressed LTBP-4 rescued the ciliary zonule phenotype in Ltbp2 null mice. In Ltbp2 null 
mice, ciliary zonule microfibrils developed when the mice were born, but were fragmented after birth, indicat-
ing an unstable microfibril structure. We reported an absence of a thick bundle structure of microfibrils in the 
zonules of these mice, which suggests that LTBP-2 is necessary for the secondary structure of microfibrils in 
ciliary zonules13. The current data demonstrate that LTBP-4 has a similar function.
It has been reported that enhanced TGF-β 2 signaling contributes to the lung septation defect in Ltbp4S null 
mice. Ltbp4S/Tgfb2 DKO mice were shown to have a lessened lung septation defect than that in Ltbp4S null 
mice at E18.5, although elastic fiber impairment was not rescued in the Ltbp4S/Tgfb2 DKO mice21. Although 
LTBP-2 does not bind TGF-β , and the lung septation defect in Ltbp4S null mice at E18.5 was not obvious in our 
experiments (Fig. 4a), it is possible that the severe emphysematous phenotype in Ltbp2/4S DKO mice may also be 
affected by increased TGF-β signaling. Further study is necessary to examine the role of TGF-β signaling in the 
pathogenesis of the emphysema present in Ltbp2/4S DKO mice.
In summary, we have demonstrated that LTBP-2 and -4 have an overlapping functions in the development of 
stable microfibril structure in vivo in the lungs, eyes, and in vitro in MEFs. In ciliary bodies, where LTBP-4 was 
scarcely expressed, Ltbp2 deficiency was sufficient to cause disruption of ciliary zonule microfibrils, which was 
compensated by ectopically overexpressed LTBP-4. Compensation of the microfibril meshwork formation in 
Ltbp2/4S DKO MEFs culture by recombinant LTBP-2 or -4, together with the electron microscopic analyses of 
mutant lungs also support this notion. Further investigation will elucidate the specific role of LTBP-2 and -4 in the 
development and organization of microfibril bundle architecture.
Materials and Methods
Mice. All mice used in this study were maintained on normal laboratory diet. Ltbp2−/− mice were generated 
with C57BL6/J ES cells and kept in pure C57BL6/J background as previously described13. Ltbp4S−/− mice18 were 
backcrossed to C57BL6/J more than 10 times before experiments. Ltbp4S KI mice, which contain CAG promot-
er-driven Ltbp4S cDNA in the Rosa26 locus (Supplementary Fig. S9), were generated using C57BL6/J ES cells 
for homologous recombination, and maintained in C57BL6/J background. All procedures were approved by the 
Committee for Animal Experiments at Kansai Medical University, and conducted according to the Guideline for 
Animal Experimentation at Kansai Medical University.
Antibodies and Immunodetection. Primary antibodies used were: chicken anti-LTBP-2 polyclonal 
(1:100, made by immunizing chickens with recombinant mouse LTBP-2, Figs 5 and 6, Supplementary Figs S6, 
S7 and S8), goat anti-LTBP-4 polyclonal (1:100; R&D Systems, Figs 5 and 6, Supplementary Figs S6, S7 and S8), 
rabbit anti-mouse fibrillin-1 polyclonal (1:100, previously described13, Figs 4–6, Supplementary Fig. S6), rabbit 
anti-elastin polyclonal PR385 (1:100; Elastin Products Company), and mouse anti-fibulin-5 monoclonal 10A 
(1:100, previously described26, Supplementary Fig. S8). Secondary antibodies conjugated with Alexa 488, 546 
and Dylight 650 were purchased from Thermo Fisher Scientific (Alexa 488 and 546) and Leinco Technologies 
(Dylight 650). Frozen sections were fixed with acetone at − 20 °C for 5 min, blocked with PBS containing 1% 
bovine serum albumin and 0.05% Triton X-100 before immunofluorescent staining. Immunofluorescence images 
were obtained using all-in-one fluorescence microscope BZ-9000 (Keyence).
Cell Culture. MEFs were maintained in DMEM (Thermo Fisher Scientific) supplemented with 2 mM glu-
tamine, 100 units/100 μ g·mL−1 penicillin/streptomycin, and 10% FBS at 37 °C in 5% CO2. For microfibril analyses, 
MEFs were cultured on coverslips in DMEM/F12 (Thermo Fisher Scientific) supplemented with 2 mM glutamine, 
100 units/100 μ g·mL−1 penicillin/streptomycin, 1x ITS-X (Thermo Fisher Scientific) with or without 3% FBS at 
37 °C in 5% CO2 for 4 days, followed by fixation with cold methanol and immunostaining. For elastic fiber analy-
ses, 10% FBS instead of ITS-X was used and culture period was extended to 14 days.
Protein Purification. Purification of recombinant LTBP-2 and -4S with a FLAG and a 6x His tag was 
described previously19,26. Briefly, these proteins were purified using TALON affinity resin (Takara) from 
serum-free conditioned medium of 293T cells stably transfected with pEF6/FLAG-LTBP-2 or -4S.
Electron Microscopy. Lung samples were fixed with 2% paraformaldehyde, 2% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7.4) at 4 °C overnight. The samples were additionally stained with 1% tannic acid in 0.1 M 
cacodylate buffer 1 hour, followed by wash and post-fixation with 2% osmium tetroxide in 0.1 M cacodylate buffer. 
The samples were embedded in resin Quetol-812 (Nisshin EM). Ultra-thin sections were stained with 2% uranyl 
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acetate and lead stain solution (Sigma-Aldrich), and were observed with transmission electron microscope JEM-
1400plus (JEOL Ltd.).
RT-PCR and qPCR. Total RNA from tissues and MEFs was extracted using TRIzol reagent (Thermo Fisher 
Scientific) and RNeasy kit (Qiagen), respectively, and transcribed to cDNA with random hexamers using 
SuperScript III First-Strand Synthesis System (Thermo Fisher Scientific). RT-PCR was performed using the prim-
ers indicated in Supplementary Table S1. For qPCR, the reaction was performed with QuantiFast SYBR Green 
PCR Kit (Qiagen), and the products were analyzed with Rotor-Gene Q (Qiagen). The primer sequences used for 
qPCR are shown in Supplementary Table S2.
Quantification of microfibrils produced by MEFs. MEFs cultured on 96-well optical bottom plate 
(Thermo Fisher Scientific) were fixed with cold methanol and reacted with anti-fibrillin-1 antibody, followed by 
staining with Alexa 488-conjugated secondary antibody and Hoechst nuclear dye. The amount of immunostained 
microfibrils and cell numbers were measured with Cellomics ArrayScan VTI system (Thermo Fisher Scientific).
Statistics. Statistical analysis of survival rate was performed by log-rank test. Statistical analyses of qPCR, 
quantification of microfibrils, and physical characteristics were performed by one-way ANOVA with Dunnett’s 
post hoc test. P < 0.05 compared to WT was considered significant.
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